SFX by Ex Libris Inc.

Title:	Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5′-diphosphates
Source:	Nature [0028-0836] Goubau, Delphine yr:2014

Basic

Full text

Full text available via Nature

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Hecht, Michael H. "Mutations in ? Repressor's Amino-Terminal Domain: Implications for Protein Stability and DNA Binding." Proceedings of the National Academy of Sciences of the United States of America 80.9 (1983): 2676-2680.
description	2.	Yen, B. "Molecular Basis for Ebola Virus VP35 Suppression of Human Dendritic Cell Maturation." Journal of virology 88.21 (2014): 12500-12510.
description	3.	Rice, N.J.V. I. "Gain-of-function mutations in IFIH1 cause a spectrum of human disease phenotypes associated with upregulated type I interferon signaling." Nature Genetics 46.5 (2014): 503-9.
description	4.	Zinzula, L. "Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: hide, mask, hit." Antiviral research 100.3 (2013): 615-635.
description	5.	Jiang, F. "Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA." Nature 454.7203 (2008): 523-7.
description	6.	PARK, D. "Ebola Virus Epidemiology, Transmission, and Evolution during Seven Months in Sierra Leone." Cell 161.7 (2015): 1516-1526.
description	7.	Raoult, D. "How the virophage compels the need to readdress the classification of microbes." Virology 477 (2014): 119-124.
description	8.	Cuadrado, E. "Aicardi-Goutières syndrome harbours abundant systemic and brain-reactive autoantibodies." Annals of the rheumatic diseases 74.10 (2014): 1931-9.
description	9.	Mühlberger, E. "Analysis of the highly diverse gene borders in Ebola virus reveals a distinct mechanism of transcriptional regulation." Journal of virology 88.21 (2014): 12558-12571.
description	10.	Klompas, M. "Ebola Fever: Reconciling Ebola Planning With Ebola Risk in U.S. Hospitals." Annals of Internal Medicine 161.10 (2014): 751-752.
description	11.	Peisley, A. "Structural basis for ubiquitin-mediated antiviral signal activation by RIG-I." Nature 509.7498 (2014): 110-4.
description	12.	Nalavade, R. "Mechanisms of RNA-induced toxicity in CAG repeat disorders." Cell Death & Disease 4.Aug. (2013).
description	13.	Liu, Jennifer M. "Development of RNA aptamers targeting Ebola virus VP35." Biochemistry 52.47 (2013): 8406-19.
description	14.	Crow, Yanick J. "THERAPIES IN AICARDI-GOUTIÃRES SYNDROME." Clinical and experimental immunology 175.1 (2013): 1-8.
description	15.	Jensen, Sren R. "Sensing of RNA viruses - A review on innate immune receptors involved in recognizing RNA virus invasion." Journal of virology 86.6 (2012): 2900-10.
description	16.	Sozzani, S. "Type I interferons in systemic autoimmunity." Autoimmunity 43.3 (2010): 196-203.
description	17.	Mateo, M. "Ebolavirus VP24 Binding to Karyopherins Is Required for Inhibition of Interferon Signaling." Journal of virology 84.2 (2010): 52-52.
description	18.	Nejentsev, S. "Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes." Science 324.5925 (2009): 387-389.
description	19.	Malathi, Robert H H. "Small self-RNA generated by RNase L amplifies antiviral innate immunity." Nature 448.7155 (2007): 816-9.
description	20.	Peng, G. "Circulating CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B infection." Immunology 123.1 (2008): 57-65.